Press Release FeedGet the RSS feed
Menu

GlobeNewswire

AltruBio to Present Data from ALTB-268 Phase 2a Trial on Ulcerative Colitis at United European Gastroenterology (UEG) Week 2026

GlobeNewswire

SAN FRANCISCO, Oct. 07, 2026 -- AltruBio Inc. (“AltruBio” or “the Company”), a clinical-stage biotech company developing novel immune modulators to address the unmet need in immunological and inflammatory diseases, today announced an oral presentation at the United European Gastroenterology (UEG) Week 2026 meeting, taking place October 17–20, 2026, in Barcelona, Spain. The presentation will feature new data from AltruBio’s Phase 2a ASCEND UC2a trial (NCT06109441) evaluating its lead asset, ALTB-268, in patients with moderately to severely active ulcerative colitis with an inadequate response to prior advanced therapy.

  1. FinanceHIMS DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HIMSWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Hims & Hers Health, Inc. (NYSE: HIMS) between August 4, 2025 and July 29, 2026, both dates inclusive (the “Class Period”), of the important November 2, 2026 lead plaintiff deadline.
  2. FinanceROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DOCSWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Doximity, Inc. (NYSE: DOCS) between August 8, 2024 and May 13, 2026, both dates inclusive (the “Class Period”), of the important November 16, 2026 lead plaintiff deadline.
  3. IndustrialBrian Kesseler Named CEO of TekniPlexVeteran industrial leader and former Tenneco CEO to lead global materials science company.
  4. CryptoCrypto News: Remittix Confirms Its Four-Product PayFi Ecosystem Ahead of Launch as Dogecoin Price Prediction Targets $0.50 and Shiba Inu Bulls Chase $0.00005Remittix brings PayFi, Markets, Wallet and Earn together ahead of the November RTX launch as Dogecoin and Shiba Inu traders target major memecoin recoveries.
  5. FinanceROSEN, THE FIRST FILING FIRM, Encourages Gildan Activewear Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - GILWHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Gildan Activewear Inc. (NYSE: GIL) between February 19, 2025 and June 15, 2026, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 14, 2026 in the securities class action first filed by the Firm.
  6. Horse Honey Capsules Introduces Horse Honey Multi-Ingredient Dietary Supplement Featuring Eleven IngredientsHorse Honey the formulation combines chromium picolinate, botanical extracts, and other plant-derived compounds in a dietary supplement intended for the adult wellness category.